Thrombolysis after acute myocardial infarction: Are Canadian physicians up to the challenge?

Williams, William L.
February 1997
CMAJ: Canadian Medical Association Journal;02/15/97, Vol. 156 Issue 4, p509
Academic Journal
Editorial. Reports that Canadian centers participating in the (Global Utilization of Streptokinase and tPA for Occluded Coronary Arteries) GUSTO-I trial were significantly slower to initiate thrombolytic therapy than their US counterparts. Reperfusion strategies using thrombolytic agents; Direct correlation between the delay to therapy and reduced survival.


Related Articles

  • Combination Thrombolytic Therapy and Percutaneous Coronary Intervention: The Future for Revascularisation for Acute Myocardial Infarction? Meredith,, Ian T.; Worthley, Stephen G.; Farouque, H. M. Omar; Zaman, Azfar G.; Meredith, Ian T. // Heart, Lung & Circulation;Oct2001, Vol. 10 Issue 2, p86 

    It seems theoretically sound to consider rescue percutaneous coronary intervention (PCI) in patients with failed thrombolysis. However, randomised controlled data in this setting are limited. In this brief review we will present those trials analysing the role of rescue PCI in patients with...

  • Another major MI study says t-PA is the best bet for early, complete reperfusion.  // Modern Medicine;Mar95, Vol. 63 Issue 3, p46 

    Presents an abstract of the article `Comparison of Front-loaded Recombinant Tissue-type Plasminogen Activator, Anistreplase and Combination Thrombolytic Therapy For Acute Myocardial Infarction: Results of the Thrombolysis in Myocardial Infarction,' by C.P. Cannon, C.H. McCabe, et al dated...

  • Related news comparing the sexes.  // Modern Medicine;Jun96, Vol. 64 Issue 6, p26 

    Reports that women with acute myocardial infarction (MI) who are treated with thrombolytic therapy have more post-MI complications than men according to investigators from the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Plasminogen Activator for...

  • Quick thrombolytic therapy reduces MI complications. Rodman, Morton J.; Hurley, Mary Lou // RN;Dec93, Vol. 56 Issue 12, p78 

    Cites the benefits of thrombolytic therapy for patients who have suffered myocardial infarction (MI) if it is administered within 70 minutes of the onset of symptoms. `JAMA' as source; Reduction in infarct size and mortality; Increased ejection fraction; Need for public education on seeking...

  • Thrombolysis in myocardial infarction. Cobre, Stuart M. // BMJ: British Medical Journal (International Edition);1/22/94, Vol. 308 Issue 6923, p216 

    Examines the use of thrombolysis in myocardial infarction. Relation between delay to thrombolytic treatment and survival benefit; Investigation on the timing of the delivery of thrombolytic treatment; Mean difference in time between the prehospital and in hospital treatment.

  • After thrombolysis, post-MI complications more likely in women.  // Geriatrics;Jun96, Vol. 51 Issue 6, p61 

    Presents the abstract of the article `Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy,' by W.D. Weaver, H.D. Wilcox et al published in a 1996 issue of the `Journal of the American Medical Association.'

  • Accelerated t-PA is treatment of choice for MI patients up to age 85. Leibovitch, Eric R. // Geriatrics;Mar97, Vol. 52 Issue 3, p75 

    Presents an abstract of the article `Age and Outcome with Contemporary Thrombolytic Therapy: Results from the GUSTO-I Trial,' by H.D. White, G.I. Barbash et al in published in `Circulation' dated 1996.

  • Lessons not learned: MI treatment recommendations from recent studies aren't followed consistently.  // Modern Medicine;Jan95, Vol. 63 Issue 1, p16 

    Reveals that thrombolytic therapy is not being used enough for myocardial infarction (MI), according to a report from the National Registry of Myocardial Infarction. Underuse of aspirin and beta blockers; Overuse of calcium channel blockers and invasive procedures; Percentage of eligible MI...

  • Time to treatment with thrombolytic therapy: Determinants and effect on short-term nonfatal... Cox, Jafna L.; Lee, Eileen // CMAJ: Canadian Medical Association Journal;02/15/97, Vol. 156 Issue 4, p497 

    Characterizes the extent of delay in administration of thrombolytic therapy to patients with acute myocardial infarction (AMI) in Canada. Examination of the patient-specific predictors of the delay; Measurement of the effect of delay on short-term nonfatal cardiac outcomes; Results and conclusions.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics